Bio Rad Laboratories Inc's fundamentals are relatively healthy, and its growth potential is high.Its valuation is considered fairly valued, ranking 39/208 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 355.00.In the medium term, the stock price is expected to trend up.Despite an average stock market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Bio Rad Laboratories Inc's Score
Industry at a Glance
Industry Ranking
39 / 208
Overall Ranking
117 / 4582
Industry
Healthcare Equipment & Supplies
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Analyst Rating
Based on
6
analysts
Buy
Current Rating
355.000
Target Price
+15.06%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Bio Rad Laboratories Inc Highlights
StrengthsRisks
Bio-Rad Laboratories, Inc. is engaged in developing, manufacturing, and marketing a range of products for the life science research and clinical diagnostics markets. The Company offers a range of products and systems used to separate complex chemical and biological materials and to identify, analyze and purify their components. It operates through two segments: Life Science and Clinical Diagnostics. The Life Science segment develops, manufactures, and markets instruments, systems, reagents, and consumables used for biological research, biopharmaceutical production processes, food testing regimes, and science education. Its Clinical Diagnostics segment designs, manufactures, markets and supports test systems, informatics systems, test kits and specialized quality controls that serve clinical laboratories in the global diagnostics market. These products are sold to hospital laboratories, diagnostic reference laboratories, transfusion laboratories, and physician office laboratories.
Fairly Valued
The company’s latest PE is -12.56, at a medium 3-year percentile range.
Institutional Selling
The latest institutional holdings are 20.58M shares, decreasing 0.02% quarter-over-quarter.
Bio-Rad Laboratories, Inc. is engaged in developing, manufacturing, and marketing a range of products for the life science research and clinical diagnostics markets. The Company offers a range of products and systems used to separate complex chemical and biological materials and to identify, analyze and purify their components. It operates through two segments: Life Science and Clinical Diagnostics. The Life Science segment develops, manufactures, and markets instruments, systems, reagents, and consumables used for biological research, biopharmaceutical production processes, food testing regimes, and science education. Its Clinical Diagnostics segment designs, manufactures, markets and supports test systems, informatics systems, test kits and specialized quality controls that serve clinical laboratories in the global diagnostics market. These products are sold to hospital laboratories, diagnostic reference laboratories, transfusion laboratories, and physician office laboratories.
Ticker SymbolBIO
CompanyBio Rad Laboratories Inc
CEOSchwartz (Norman D)
Websitehttps://www.bio-rad.com/
FAQs
What is the current price of Bio Rad Laboratories Inc (BIO)?
The current price of Bio Rad Laboratories Inc (BIO) is 300.930.
What is the symbol of Bio Rad Laboratories Inc?
The ticker symbol of Bio Rad Laboratories Inc is BIO.
What is the 52-week high of Bio Rad Laboratories Inc?
The 52-week high of Bio Rad Laboratories Inc is 373.690.
What is the 52-week low of Bio Rad Laboratories Inc?
The 52-week low of Bio Rad Laboratories Inc is 211.430.
What is the market capitalization of Bio Rad Laboratories Inc?
The market capitalization of Bio Rad Laboratories Inc is 8.12B.
What is the net income of Bio Rad Laboratories Inc?
The net income of Bio Rad Laboratories Inc is -1.84B.
Is Bio Rad Laboratories Inc (BIO) currently rated as Buy, Hold, or Sell?
According to analysts, Bio Rad Laboratories Inc (BIO) has an overall rating of Buy, with a price target of 355.000.
What is the Earnings Per Share (EPS TTM) of Bio Rad Laboratories Inc (BIO)?
The Earnings Per Share (EPS TTM) of Bio Rad Laboratories Inc (BIO) is -24.014.